See All Slides - tctmd.com

Slides

Presentation TCT 2012

Anticoagulation Choices for Atrial Fibrillation: Which Drug for Which Patient?

Presenter: Michael Ezekowitz

October 24, 2012

Presentation TCT 2012

Bifurcation Lesion Stenting: Impact of Stent Geometry and Technique on Outcomes (and Potential of Dedicated Bifurcation Stents)

Presenter: John Ormiston

October 24, 2012

Presentation TCT 2012

Clinical Outcomes After the MitraClip: Risks vs. Benefits (in FMR vs. DMR)

Presenter: Howard Herrmann

October 24, 2012

Presentation TCT 2012

Management of Fibromuscular Dysplasia of the Carotid Artery

Presenter: Jeffrey Olin

October 24, 2012

Presentation TCT 2012

Late Complication After Rotational Atherectomy

Presenter: Edouard Benit

October 24, 2012

Presentation TCT 2012

Should P2Y12 Antagonists Be Continued Through CABG in Patients with ACS?

Presenter: Adnan Kastrati

October 24, 2012

Presentation TCT 2012

Troubleshooting Loss of Visualization During Dissection Reentry

Presenter: James Spratt

October 24, 2012

Presentation TCT 2012

Minimally Invasive Mitral Repair: Is It for Everyone (Surgeon and Patient)?

Presenter: A. Marc Gillinov

October 24, 2012

Presentation TCT 2012

Two Instructive Carillon Cases: One That Worked and One That Didn't

Presenter: Joachim Schofer

October 24, 2012

Presentation TCT 2012

Clopidogrel Is Still the Choice for Most!

Presenter: Shamir Mehta

October 24, 2012

Advertisement

Slides

Anticoagulation Choices for Atrial Fibrillation: Which Drug for Which Patient?

Bifurcation Lesion Stenting: Impact of Stent Geometry and Technique on Outcomes (and Potential of Dedicated Bifurcation Stents)

Clinical Outcomes After the MitraClip: Risks vs. Benefits (in FMR vs. DMR)

Management of Fibromuscular Dysplasia of the Carotid Artery

Late Complication After Rotational Atherectomy

Should P2Y12 Antagonists Be Continued Through CABG in Patients with ACS?

Troubleshooting Loss of Visualization During Dissection Reentry

Minimally Invasive Mitral Repair: Is It for Everyone (Surgeon and Patient)?

Two Instructive Carillon Cases: One That Worked and One That Didn't

Clopidogrel Is Still the Choice for Most!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content